Epidemiology of severe heart disease among Unified Health System (SUS) users in Rio Grande do Norte: a

Gustavo Gomes Torres1, Angelo Giuseppe Roncalli2

  • 1Programa de Pós-Graduação em Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Insights

This study analyzed 894 patients undergoing artificial cardiac stimulation (ACS) for severe heart disease. Findings reveal a random spatial distribution of cases, suggesting adequate service accessibility.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Severe heart disease presents significant prevalence, morbidity, and mortality.
  • Artificial cardiac stimulation (ACS) is crucial in advanced heart disease management.
  • Service-based procedure analysis aids population health insights.

Purpose of the Study:

  • To determine the epidemiological profile of severe heart disease patients in Rio Grande do Norte.
  • To document all patients receiving ACS within a Unified Health System reference center.
  • To analyze the spatial distribution of severe heart disease cases.

Main Methods:

  • Cross-sectional study of 894 patients undergoing ACS from 2006-2021.
  • Data collection included sociodemographic factors, procedures, and health conditions.
  • Spatial analysis assessed case distribution by municipality.

Main Results:

  • The cohort comprised 59.8% males with a mean age of 65.5 years.
  • Common indications included third-degree atrioventricular block (191 patients) and ischemic etiology (269 patients).
  • Hypertension (69.5%), dyspnea (398 patients), diabetes (24.4%), and dyslipidemia (31.7%) were prevalent. Spatial analysis showed no significant clustering.

Conclusions:

  • The study's service-specific characteristics may influence findings compared to literature.
  • Severe heart disease distribution was random across the state.
  • This suggests adequate access to reference services, even without a formal care flowchart.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
67
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
37
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
38
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
52
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40